3.8

CiteScore

2.4

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Ping Wang, Satoru Naruse, Hong Yin, Zhongfang Yu, Tianqu Zhuang, Wei Ding, Yanmin Wu, Muxin Wei. The susceptibility of T5-TG12 of the CFTR gene in chronic bronchitis occurrence in a Chinese population in Jiangsu province, China[J]. The Journal of Biomedical Research, 2012, 26(6): 410-417. DOI: 10.7555/JBR.26.20120015
Citation: Ping Wang, Satoru Naruse, Hong Yin, Zhongfang Yu, Tianqu Zhuang, Wei Ding, Yanmin Wu, Muxin Wei. The susceptibility of T5-TG12 of the CFTR gene in chronic bronchitis occurrence in a Chinese population in Jiangsu province, China[J]. The Journal of Biomedical Research, 2012, 26(6): 410-417. DOI: 10.7555/JBR.26.20120015

The susceptibility of T5-TG12 of the CFTR gene in chronic bronchitis occurrence in a Chinese population in Jiangsu province, China

Funds: 

the Key Talent's Subsidy Project in Science and Education of the Jiangsu Province (No. 2007158)

More Information
  • Received Date: February 21, 2012
  • Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been implicated in the onset of cystic fibrosis and other clinical respiratory disorders. In the present study, we investigated the role of CFTR variations, poly-T, TG-repeats, and M470V in susceptibility to bronchial asthma and chronic bronchitis in a Chinese population in Jiangsu province, China. A total of 72 bronchial asthma patients, 68 chronic bronchitis pa-tients, and 117 healthy subjects were included in this study. The Tn-TGm haplotype was sequenced and the CFTR variant M470V was detected using restriction fragment length polymorphism (RFLP). We found that the fre-quency of T5-TG12-V470 in chronic bronchitis patients was 0.07%, which was notably higher than that in healthy subjects (0.01%) and bronchial asthma patients (0.04%). Thus, the presence of the T5-TG12 haplotype of the CFTR gene is likely to play a role in the development and progression of respiratory conditions, such as chronic bronchitis.
  • Related Articles

    [1]Pei Wang, Xiaowei Wei, Xiaojun Qu, Yefei Zhu. Potential clinical application of microRNAs in bladder cancer[J]. The Journal of Biomedical Research, 2024, 38(4): 289-306. DOI: 10.7555/JBR.37.20230245
    [2]Sahil Khurana, Ajay Pal Singh, Ashok Kumar, Rajeev Nema. Prognostic value of AKT isoforms in non-small cell lung adenocarcinoma[J]. The Journal of Biomedical Research, 2023, 37(3): 225-228. DOI: 10.7555/JBR.36.20220138
    [3]Sun Zhen, Liu Chen, Cheng Steven Y.. Identification of four novel prognosis biomarkers and potential therapeutic drugs for human colorectal cancer by bioinformatics analysis[J]. The Journal of Biomedical Research, 2021, 35(1): 21-35. DOI: 10.7555/JBR.34.20200021
    [4]Huanqiang Wang, Congying Yang, Siyuan Wang, Tian Wang, Jingling Han, Kai Wei, Fucun Liu, Jida Xu, Xianzhen Peng, Jianming Wang. Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer[J]. The Journal of Biomedical Research, 2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065
    [5]Jianming Wu, Ling Li. Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications[J]. The Journal of Biomedical Research, 2016, 30(5): 361-372. DOI: 10.7555/JBR.30.20150131
    [6]Tinghua Hu, Yu Yao, Shuo Yu, Hui Guo, Lili Han, Wenjuan Wang, Tao Tian, Yibin Hao, Zhiyan Liu, Kejun Nan, Shuhong Wang. Clinicopathologic significance of CXCR4 and Nrf2 in colorectal cancer[J]. The Journal of Biomedical Research, 2013, 27(4): 283-290. DOI: 10.7555/JBR.27.20130069
    [7]Songyu Cao, Cheng Wang, Xinen Huang, Juncheng Dai, Lingmin Hu, Yao Liu, Jiaping Chen, Hongxia Ma, Guangfu Jin, Zhibin Hu, Lin Xu, Hongbing Shen. Prognostic assessment of apoptotic gene polymorphisms in non-small cell lung cancer in Chinese[J]. The Journal of Biomedical Research, 2013, 27(3): 231-238. DOI: 10.7555/JBR.27.20130014
    [8]Wenze Sun, Liping Song, Ting Ai, Yingbing Zhang, Ying Gao, Jie Cui. Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer[J]. The Journal of Biomedical Research, 2013, 27(3): 220-230. DOI: 10.7555/JBR.27.20130004
    [9]Lihong Chen, Lianxiang Li, Feng Chen, Dalin He. Immunoexpression and prognostic role of p53 in different subtypes of epithelial ovarian carcinoma[J]. The Journal of Biomedical Research, 2012, 26(4): 274-277. DOI: 10.7555/JBR.26.20110103
    [10]Shuangshuang Wang, Ping Zhao, Brian Cao. Development and optimization of an antibody array method for potential cancer biomarker detection[J]. The Journal of Biomedical Research, 2011, 25(1): 63-70. DOI: 10.1016/S1674-8301(11)60008-0
  • Cited by

    Periodical cited type(6)

    1. Bühler M, Fahrländer J, Sauter A, et al. GPER1 links estrogens to centrosome amplification and chromosomal instability in human colon cells. Life Sci Alliance, 2022, 6(1): e202201499. DOI:10.26508/lsa.202201499. Print 2023 Jan
    2. Bühler M, Stolz A. Estrogens-Origin of Centrosome Defects in Human Cancer?. Cells, 2022, 11(3): 432. DOI:10.3390/cells11030432
    3. Kalkan BM, Ozcan SC, Quintyne NJ, et al. Keep Calm and Carry on with Extra Centrosomes. Cancers (Basel), 2022, 14(2): 442. DOI:10.3390/cancers14020442
    4. Jia ZH, Wang XG, Zhang H. Overcome cancer drug resistance by targeting epigenetic modifications of centrosome. Cancer Drug Resist, 2019, 2(2): 210-224. DOI:10.20517/cdr.2018.010
    5. Li JA, Liu BC, Song Y, et al. Cyclin A2 regulates symmetrical mitotic spindle formation and centrosome amplification in human colon cancer cells. Am J Transl Res, 2018, 10(8): 2669-2676.
    6. Harrison LE, Bleiler M, Giardina C. A look into centrosome abnormalities in colon cancer cells, how they arise and how they might be targeted therapeutically. Biochem Pharmacol, 2018, 147: 1-8. DOI:10.1016/j.bcp.2017.11.003

    Other cited types(0)

Catalog

    Muxin Wei

    1. On this Site
    2. On Google Scholar
    3. On PubMed

    Article Metrics

    Article views (4332) PDF downloads (1324) Cited by(6)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return